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2013.01.0Abstract Background: Small intestinal cancers (SICs) are very rare all over the world and little is
known about them in Egypt.
Methods: This a retrospective study. Between 2000 and 2002, 30 cases with SICs were identiﬁed in
the Gharbiah population based cancer registry (GPBCR); 17 cases of whom were treated at Tanta
Cancer Center (TCC).
Results: The median age was 51 years with female predominance. The duodenum was the com-
monest site (43%) followed by the ileum then the jejunum. Adenocarcinoma (AC), carcinoids, gas-
trointestinal stromal tumors (GISTs), lymphoma and sarcoma represented 50%, 10%, 17%, 13%
and 10% respectively. Abdominal pain was the commonest symptom and localized disease was the
commonest presentation. Surgery, chemotherapy and radiotherapy were employed in 65%, 35%
and 0% of patients, respectively. The median overall survival and progression free survival (OS,
PFS) were 18 and 15 months (95% CI: 10.4–25.6 and 3.6–26.4), respectively. AC had inferior OS
and PFS to other histologies (p= 0.08 and 0.12, respectively). Also, duodenum subsite was inferior
in OS and PFS to other sites (p= 0.25 and 0.35, respectively).sociate Professor of Medical
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Table 1 Characteristics of 30 patie
TCC.
Characteristic GPBCR
Total 30 (100
Sex
Male 12 (40)
Female 18 (60)
Site
Duodenum 13 (43)
Jejunum 4 (13)
Ileum 6 (20)
NOS 7 (24)
Histology
Adenocarcinoma 15 (50)
Malignant carcinoid 3 (10)
NHL 4 (13)
GIST 5 (17)
Leiomyosarcoma 3 (10)
SEER Stage
Localized 14 (47)
Regional 7 (23)
Distant 5 (17)
Unknown 4 (13)
GPBCR: Gharbiah population based
miology and End Results, NHL: non-
108 A.A. Zeeneldin et al.Conclusions: SICs in Gharbiah, Egypt are characterized by predominance of female gender and
adenocarcinoma histology. One year survival is 64% with a poor outcome for adenocarcinoma
and duodenal subsite.
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Despite the small intestine being the longest part of the bowel,
small intestinal cancer (SIC) is a rare disease compared to can-
cer in shorter parts like the colon and the stomach. SICs ac-
count for less than 5% of gastrointestinal cancers (GITCs)
[1]. Differences in microbial ﬂora, metabolism of bile acids,
and transit time may account for the variation [2]. The risk fac-
tors for SICs include cigarette smoking, alcohol intake, and
other medical conditions including Chron’s disease and famil-
ial adenomatous polyposis (FAP), cholecystectomy, peptic ul-
cer disease, and cystic ﬁbrosis [1].
SICs show geographical, sex, age, racial and temporal vari-
ations in different parts of the world [1,3]. Age-standardized
rates (ASRs) per 100,000 population vary from 0.1 in Zimba-
bwe to 3 in the USA. Male predominance is the commonest
where female predominance is noticed occasionally [3]. The
incidence increases with age and blacks have higher ASR than
whites [2,4]. Moreover, many authors reported rising inci-
dences of SICs [1,2,4]. The geographical and temporal varia-
tions suggest that environmental factors play an important
role in the etiology of SICs [1].nts with small intestinal cancers
cases number (%) TCC ca
) 17 (100
7 (41)
10 (59)
7 (41)
4 (24)
1 (6)
5 (29)
9 (53)
1 (6)
1 (6)
3 (18)
3 (18)
11 (65)
1 (6)
5 (29)
0 (0)
cancer registry, TCC: Tanta Canc
Hodgkin’s lymphoma, GIST: gastrLittle is known about SICs in Egypt. Thus, we conducted
this study to recognize the clinicopathological features, presen-
tations, treatments and outcomes of SICs in Egypt.
Methods
This is a retrospective study. Patients with SICs were identiﬁed
through the Gharbiah population based cancer registry
(GPBCR). Data on age, sex, sub-site, histology, grade, stage
and treating center were obtained from the registry. Further
data on complaints, comorbidities, treatment modalities, re-
lapse, dates of diagnosis, surgery and relapse, and survival
were obtained for those subset of patients treated at Tanta
Cancer Center (TCC). The study was approved by the IRB
of the Egyptian National Cancer Institute.
Inclusion criteria were adult patients (age of 18 years or
more) with SIC and a conﬁrmed malignant histology between
2000 and 2002. Exclusion criteria were non-conﬁrmed histo-
logic subtype as those diagnosed based on death certiﬁcate,
radiology or unspeciﬁed malignant type.
Between 2000 and 2002, 34 cases with SICs contained
GPBCR were identiﬁed. Four cases of which were excludedhistologically conﬁrmed at GPBCR including 17 cases treated at
ses number (%) Non-TCC cases number (%) P value
) 13 (100)
5 (39)
8 (61) 0.88
6 (46)
0 (0)
5 (39)
2 (15) 0.24
6 (46)
2 (15)
3 (24)
2 (15)
0 (0) 0.81
3 (24)
6 (46)
0 (0)
4 (30) 0.01
er Canter, NOS: not otherwise speciﬁed, SEER: Surveillance Epide-
ointestinal stromal tumor.
Table 2 More details on 17 patients with small intestinal
cancers who presented to Tanta Cancer Canter.
Characteristic Number %
Complaints
Abdominal pains only 7 41
Intestinal obstruction 2 12
Vomiting and pains 2 12
Diarrhea 2 12
None/unknown 4 23
Co-morbidities
No 6 35
Yes 6 35
Unknown 5 30
Surgery
Yes 11 65
No 3 17.5
Unknown 3 17.5
Chemotherapy
Yes 6 35
No 8 47
Unknown 3 18
Chemotherapy regimens
5-FU based 4 23
CHOP 1 6
Doxorubicin 1 6
None 11 65
Relapses (12 cases)*
Yes 4 33
No 5 42
Unknown 3 25
* 5 patients were metastatic at initial presentation and not included
here. 5-FU: 5- ﬂuorouracil, CHOP: cyclophosphamide, doxorubi-
cin, vincristine, prednisolone.
Small intestinal cancers among adults in an Egyptian district: 109being diagnosed based on the death certiﬁcates, radiologic
appearance or clinical ﬁndings during exploration with no his-
topathological conﬁrmation.
Statistical analysis
All analyses were done using SPSS software program version
15 (Chicago, USA). Nominal and categorical data were com-
pared for different histologies (adenocarcinoma (AC) vs.
non-AC) and subsite (duodenum vs. others) using the Chi
squared test. Survival was calculated using the Kaplan Meyer
methods and groups were compared using the log-rank test. A
probability (p) equal to or less than 0.05 (two sided) was con-
sidered statistically signiﬁcant.
Results
SICs represented 4% of GIT cancers. The median age was
51 years (range, 20–78 years). Female predominance was no-
ticed (1.5:1) and this predominance was noticed with duode-
num and other subsites, and with Adenocarcinoma (AC),
gastro-intestinal stromal tumors (GIST) and leiomyosarcoma
but not with carcinoids or lymphoma. The duodenum was
the commonest involved site (43%). However, the site was
not mentioned in one quarter of cases. AC was the commonest
histology (50%) while malignant carcinoids were encountered
in 3 cases. There were 4 cases of non-Hodgkin’s lymphoma;
two were diffuse large B-cell type, one marginal zone type
and one unspeciﬁed. There were 5 cases of GIST and three
of them were low-grade. Most (10/13) of duodenal tumors
(69%) were ACs and most (10/15) of ACs affected the duode-
num (67%). Most of non-AC (75%) affected the jejunum and
ileum. Table 1 shows the characteristics of patients involved in
the current study. Most patients had a non-metastatic disease
either local or regional. Metastases were documented at initial
presentation in ﬁve patients. All involved the liver with the
pancreas being additionally involved in one case.
Clinical data particularly pertaining to treatment and fol-
low up, other than those mentioned previously, were not con-
tained in GPBCR. Thus we tried to further track as much cases
as possible through reviewing cases that presented to TCC, the
main oncology center in Gharbiah governorate, Egypt. We
could identify 17 cases whose information is discussed below
in more detail.
TCC cases were similar to those of GPBCR. TCC cases had
higher local and distant diseases and a lower regional disease
than non-TCC cases (P= 0.01; Table 1). Otherwise, TCC
and non-TCC cases were not signiﬁcantly different. Most
TCC patients had symptoms related to their disease with
abdominal pains being the commonest. One third of the pa-
tients had concurrent co-morbidities; diabetes (2/6), hyperten-
sion (2/6), both (1/6) and hepatic cirrhosis (1/6).
While none received radiotherapy, most patients (65%)
underwent surgery that was deﬁnitive (9/11) or palliative (4/
11). One third of patients received chemotherapies that were
5-ﬂuorouracil based in patients with AC (4/6), CHOP (cyclo-
phosphamide, doxorubicin, vincristine, prednisolone) in one
case with NHL and doxorubicin in one case with leiomyosar-
coma. For patients with AC, chemotherapy was given
adjuvantly for node positive disease in two patients and pallia-tively in the metastatic setting of two patients. Only 4 patients
had documented relapses that were local in all cases (Table 2).
After a median follow up of 26 months (range 25–104), 4/17
patients relapsed and 11/17 were dead. Deaths were disease re-
lated in 9/11 cases. The median overall survival (OS) was
18 months (95% CI 10.4–25.6; Figure 1). The one- and two-
year OS rates were 64% and 38%, respectively. The median
progression free survival (PFS) was 15 months (95% CI 3.6–
26.4; Figure 2). The one- and two-year PFS survival rates were
51% and 32%, respectively.
Comparing AC to non-AC histology showed that both OS
and PFS were inferior in the AC group. The one- and two-year
OS for AC were 56% and 22% and for non-AC were 73% and
58%, respectively. The one- and two-year PFS for AC were
44% and 22% and for non-AC were 58% and 43%, respec-
tively. However, the differences were not statistically signiﬁ-
cant (p= 0.08 and 0.12; Figures. 3 and 4, respectively).
Comparing SIC subsites showed that both OS and PFS were
inferior for the duodenum than other subsites. The one- and
two-year OS for duodenal site were 43% and 29% and for
non-duodenal sites were 68% and 45%, respectively. The
one- and two-year PFS for duodenal site were 43% and 43%
and for non-duodenal sites were 67% and 34%, respectively.
However, the differences were not statistically signiﬁcant
(p= 0.25 and 0.35; Figures. 5 and 6 respectively).
Figure 1 Overall survival in 17 patients with small intestinal cancers.
Figure 2 Progression-free survival of 17 patients with small intestinal cancer.
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Figure 3 Overall survival in patients with adenocarcinoma vs. other cancers of the small intestine (p= 0.12).
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Despite the relatively small numbers, this is the ﬁrst popula-
tion-based study comprehensively reporting SICs in Egypt
particularly the information related to treatments and their
outcomes including recurrences and survival.
In Egypt, SICs represented 4% of GI cancers and 0.8% of
the total cancers comparable to 3.6% and 0.5% in the USA [5].
ASRs of SICs in Egypt are similar to those in many countries
[3,6,7]. However, age of SICs in Egypt is one decade below that
of industrialized countries like the USA [1]. Age differences be-
tween Egypt and Western countries were also noted in many
cancers including breast cancer, colon cancer and liver cancer
[8–11]. This age difference may be explained by differences in
population structures with lower life expectancy and younger
median population age among Egyptians compared to Wes-
tern countries [12,13].
Sex variation of SICs across different geographic regions is
reported in the literature [2,3,14–18]. Similar to reports from
Hawaii, Philippines, French Polynesia, Russia St. Petersburg,
Spain Cuenca, Turkey Izmir, Kuwait and some areas of Swit-
zerland, the current study showed that females are more af-
fected than males, [3,14]. However, other authors showed a
reverse pattern in North America and Europe [2,15–18]. Most
of the registries that showed female predominance, like ours,
reported on small SIC numbers mostly in less developed re-
gions and those showing male predominance reported on big
numbers in more developed regions [3]. Female predominance
in the current study, in contrast with male predominance in
bigger reports from Western countries, could be reasoned by
differences in genetic constitutions, susceptibilities and expo-
sure to risk factors. Obesity and alcohol were mentioned inmany reports to be risk factors for SICs [19–24]. Thus, differ-
ences in obesity and alcohol intake might partially explain for
the SIC’ sex variation between Egypt and Western countries.
Almost 72% of women and 50% of men in Egypt were over-
weight or obese [25] compared to a reverse pattern in the US
(57% in females and 70% in males) [26]. While drinking alco-
holic beverages is occasional among Egyptian males and fe-
males [27], almost 87% of US males and 63% of US females
drink alcohol [28]. Thus, the more alcoholic drinking and obes-
ity in males might explain for the predominance of SICs in
males, while the paucity of alcohol use in Egyptian males
and females may lead the overweight issue to be a key player
to get male SIC predominance among Egyptians.
SICs in Egypt, as shown in this study, are characterized by a
higher incidence ofAC, resembling industrialized countries, and
a lower incidence of lymphoma unlike the developing countries
[1]. While the percentages of sarcomas and lymphomas in the
current study are similar to those from other population-based
cancer registries from the USA [2,29,30], England & Wales
and Scotland [4], the incidence of malignant carcinoids was low-
er and that of AC which was higher. While this could be a true
ﬁnding related to genetic, racial or environmental factors, it
may reﬂect under diagnosis of carcinoids and over diagnosis
of AC. Some cases of carcinoids may be diagnosed as AC. This
can be plausible particularly that carcinoid diagnosis is not a
sole light microscopical diagnosis for the most part, but rather
amultidisciplinary diagnosticmodel using biochemical analysis,
standard cross-sectional imaging, newer advances in nuclear
medicine and immunohistochemical studies [31]. This may also
be a random variation associated with relatively low number of
cases [4]. Also, exclusion of pediatric SICsmay have contributed
to the underrepresentation of lymphomas.
Figure 4 Progression-free survival in patients with adenocarcinoma vs. other cancers of the small intestine (p= 0.08).
Figure 5 Overall survival of small intestinal cancer according to subsite; duodenum vs. other sites (p= 0.25).
112 A.A. Zeeneldin et al.Similar to reports from the USA, England & Wales and
Scotland [4,29], we showed that the duodenum was the com-
monest subsite followed by the ileum and then the jejunum.
While the percentage of jejunal and SICs NOS (not otherwisespeciﬁed) in the current study was similar to that from other
population-based cancer registries from the USA [1,2], the
percentage of ileal SICs was lower and that of duodenal SICs
was higher. The reason for this is unknown. However, the
Figure 6 Progression-free survival in small intestinal cancers according to subsite; duodenum vs. other sites (p= 0.35).
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effect on the percentage. Also, racial and environmental fac-
tors could be players.
Site and histology are linked as most of carcinoids being lo-
cated in the ileum andmost ACs being located in the duodenum
[1]. In the current study, only 20%of SICs affected the ileumand
this was reﬂected on paucity of carcinoids. Also, the small abso-
lute numbers in the current study together with exclusion of 4
cases with unknown histology can partly explain for that. How-
ever, ethnic, genetic and environmental factors [2,3] as well as
geographical variations [3] may contribute to the differences.
The OS in our study is similar to that from Scotland and
England & Wales [4]. The one year OS (64%) is similar to re-
ports from the USA (74%) [2]. Similar to Qubaiah and his col-
leagues, we showed that the OS of AC and duodenal subite
were less favorable than other histologies and subsites [2].
The worse outcome of duodenal cancers despite the potential
for early detection may relate to the dominance of aggressive
cancers (ACs vs. other histologies) that may be less responsive
to therapeutic interventions including technical difﬁculties for
surgical resection [2].
In conclusion, SICs are a rare disease among adult Egyptians
residing in Gharbiah district. It is characterized by predominance
of female gender, duodenal site and adenocarcinoma histology.
Surgery is the main therapeutic modality and chemotherapy
was infrequently encountered. Survival outcomes are comparable
to other populations.
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